Release Date: 24/10/19 09:37 Summary: IHL completes $5m capital raise Price Sensitive: Yes Download Document 170.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%